Skip to content

Effect Of The Mediterranean Diet On Zonulin And Infertility

Evaluation Of The Effect Of Mediterranean Diet On Serum Zonulin Levels And Treatment Success In Women Infertility

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07072936
Enrollment
22
Registered
2025-07-18
Start date
2024-02-10
Completion date
2024-08-30
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Female, Intestinal Permeability, Mediterranean Diet, Zonulin

Keywords

female infertility, serum zonulin, mediterranean diet, clinical pregnancy

Brief summary

The goal of this clinical trial is to learn if mediterranean diet works to treat infertility in women. It will also learn about the initial and end of study zonulin levels of mediterranean diet and control group. The main questions it aims to answer are: * Does mediterranean diet lower the serum zonulin levels of participants? * Does mediterranean diet improves the treatment success of participants with infertility? Researchers will compare mediterranean to a control group to see if diet works to treat infertility. Participants will: * Apply Mediterranean diet or routine diet without energy restriction for 8 weeks * Visit the clinic once every 4 weeks for checkups and tests

Interventions

BEHAVIORALmediterranean diet

All questions of the intervention group, in which behavioural change was expected, were answered by the dietitian throughout the study and compliance with the diet was monitored with food consumption records.

Sponsors

SINEM BAYRAM
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Being in the range of 18.5-29.9 kg/m2 BMI * Having started infertility treatment

Exclusion criteria

* Having a chronic disease (diabetes mellitus, hypertension, etc.) * Previous ovarian surgery * Being diagnosed with PCOS, endometriosis * Known autoimmune disease * Thyroid disease

Design outcomes

Primary

MeasureTime frameDescription
intestinal permeabilityFrom enrollment to the end of treatment at 8 weeksserum zonulin levels

Secondary

MeasureTime frameDescription
infertility outcomesFrom enrollment to the end of treatment at 8 weeksnumber of eggs collected

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026